Pharmacists in Raynham, Massachusetts


13 Pharmacists found in Raynham
female pharmacist

Amy Katherine Losordo


Pharmacist
160 Broadway, Raynham, MA 02767
508-692-6751    

male pharmacist

Andrew Rose


Pharmacist
266 New State Hwy, Raynham, MA 02767
508-824-1361    

female pharmacist

Dr. Brittany Lanee Dwyer, PHARMD


Pharmacist
36 Paramount Dr, Raynham, MA 02767
508-822-7122     508-822-1784



female pharmacist

Cynthia Boboruzian, RPH


Pharmacist
252 Broadway, Raynham, MA 02767
508-824-8621    

male pharmacist

Dr. David Melancon, PHARMD


Pharmacist
266 New State Hwy, Raynham, MA 02767
508-824-1361     508-824-8779

female pharmacist

Dr. Erica April Adler, PHARMD, RPH


Pharmacist
266 New State Hwy, Raynham, MA 02767
508-824-1361    

female pharmacist

Dr. Grace Leewan To, PHARMD


Pharmacist
160 Broadway, Raynham, MA 02767
508-692-6751     508-692-6751

female pharmacist

Jennifer Mcaloon


Pharmacist
36 Paramount Dr, Raynham, MA 02767
508-822-7122    

female pharmacist

Naina Mulki, RPH


Pharmacist
266 New State Hwy, Raynham, MA 02767
508-824-1361    

male pharmacist

Rolf Alphonse, PHARMACIST


Pharmacist
266 Rte 44 Raynham, Raynham, MA 02767
508-824-1361    

female pharmacist

Dr. Stacie Ann Morgado


Pharmacist
266 New State Hwy, Raynham, MA 02767
508-824-1361    

female pharmacist

Tayla Ross, RPH


Pharmacist
252 Broadway, Raynham, MA 02767
508-824-8621    

male pharmacist

Thomas F Eisenmann, RPH


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
266 New State Hwy, Raynham, MA 02767
508-824-1361    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.